APG Asset Management US’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,281
Closed -$547K 94
2025
Q3
$547K Hold
8,281
﹤0.01% 158
2025
Q2
$692K Hold
8,281
0.01% 148
2025
Q1
$557K Hold
8,281
﹤0.01% 156
2024
Q4
$644K Sell
8,281
-13,086
-61% -$969K ﹤0.01% 146
2024
Q3
$1.41M Sell
21,367
-188,547
-90% -$15.5M 0.01% 110
2024
Q2
$23.5M Buy
209,914
+25,951
+14% +$3.28M 0.13% 91
2024
Q1
$25.4M Buy
183,963
+85,595
+87% +$10.8M 0.15% 84
2023
Q4
$12.2M Buy
+98,368
New +$10M 0.07% 97

Other funds holding DXCM

APG Asset Management US's DXCM Position: Q4 2025 in Review

APG Asset Management US sold out of DexCom (DXCM) in Q4 2025, closing a stake of 8,281 shares — an estimated $547K sold.

APG Asset Management US first reported a position in DXCM in Q4 2023 and held it in 8 quarters. The position peaked at $25.4M in Q1 2024. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • APG Asset Management US reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 8,281 DexCom shares in Q4 2025, an estimated $547K.
  • APG Asset Management US first reported a position in DexCom in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's DexCom position peaked at $25.4M in Q1 2024.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.